2024-04-20 18:24:05, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_001164000 5740 bp mRNA linear PRI 16-JUN-2013 DEFINITION Homo sapiens MDS1 and EVI1 complex locus (MECOM), transcript variant 6, mRNA. ACCESSION NM_001164000 VERSION NM_001164000.1 GI:255683389 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 5740) AUTHORS Senyuk,V., Zhang,Y., Liu,Y., Ming,M., Premanand,K., Zhou,L., Chen,P., Chen,J., Rowley,J.D., Nucifora,G. and Qian,Z. TITLE Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis JOURNAL Proc. Natl. Acad. Sci. U.S.A. 110 (14), 5594-5599 (2013) PUBMED 23509296 REMARK GeneRIF: EVI1 binds to the promoter of miR-9-3, leading to DNA hypermethylation of the promoter and repression of miR-9. REFERENCE 2 (bases 1 to 5740) AUTHORS Hwang,J.Y., Lee,S.H., Go,M.J., Kim,B.J., Kou,I., Ikegawa,S., Guo,Y., Deng,H.W., Raychaudhuri,S., Kim,Y.J., Oh,J.H., Kim,Y., Moon,S., Kim,D.J., Koo,H., Cha,M.J., Lee,M.H., Yun,J.Y., Yoo,H.S., Kang,Y.A., Cho,E.H., Kim,S.W., Oh,K.W., Kang,M.I., Son,H.Y., Kim,S.Y., Kim,G.S., Han,B.G., Cho,Y.S., Cho,M.C., Lee,J.Y. and Koh,J.M. TITLE Meta-analysis identifies a MECOM gene as a novel predisposing factor of osteoporotic fracture JOURNAL J. Med. Genet. 50 (4), 212-219 (2013) PUBMED 23349225 REFERENCE 3 (bases 1 to 5740) AUTHORS Steinleitner,K., Rampetsreiter,P., Koffel,R., Ramanathan,G., Mannhalter,C., Strobl,H. and Wieser,R. TITLE EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages JOURNAL Anticancer Res. 32 (11), 4883-4889 (2012) PUBMED 23155256 REMARK GeneRIF: EVI1 is expressed in human hematopoietic progenitor cells, but is down-regulated during differentiation REFERENCE 4 (bases 1 to 5740) AUTHORS Hancock,D.B., Artigas,M.S., Gharib,S.A., Henry,A., Manichaikul,A., Ramasamy,A., Loth,D.W., Imboden,M., Koch,B., McArdle,W.L., Smith,A.V., Smolonska,J., Sood,A., Tang,W., Wilk,J.B., Zhai,G., Zhao,J.H., Aschard,H., Burkart,K.M., Curjuric,I., Eijgelsheim,M., Elliott,P., Gu,X., Harris,T.B., Janson,C., Homuth,G., Hysi,P.G., Liu,J.Z., Loehr,L.R., Lohman,K., Loos,R.J., Manning,A.K., Marciante,K.D., Obeidat,M., Postma,D.S., Aldrich,M.C., Brusselle,G.G., Chen,T.H., Eiriksdottir,G., Franceschini,N., Heinrich,J., Rotter,J.I., Wijmenga,C., Williams,O.D., Bentley,A.R., Hofman,A., Laurie,C.C., Lumley,T., Morrison,A.C., Joubert,B.R., Rivadeneira,F., Couper,D.J., Kritchevsky,S.B., Liu,Y., Wjst,M., Wain,L.V., Vonk,J.M., Uitterlinden,A.G., Rochat,T., Rich,S.S., Psaty,B.M., O'Connor,G.T., North,K.E., Mirel,D.B., Meibohm,B., Launer,L.J., Khaw,K.T., Hartikainen,A.L., Hammond,C.J., Glaser,S., Marchini,J., Kraft,P., Wareham,N.J., Volzke,H., Stricker,B.H., Spector,T.D., Probst-Hensch,N.M., Jarvis,D., Jarvelin,M.R., Heckbert,S.R., Gudnason,V., Boezen,H.M., Barr,R.G., Cassano,P.A., Strachan,D.P., Fornage,M., Hall,I.P., Dupuis,J., Tobin,M.D. and London,S.J. TITLE Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function JOURNAL PLoS Genet. 8 (12), E1003098 (2012) PUBMED 23284291 REFERENCE 5 (bases 1 to 5740) AUTHORS Haas,K., Kundi,M., Sperr,W.R., Esterbauer,H., Ludwig,W.D., Ratei,R., Koller,E., Gruener,H., Sauerland,C., Fonatsch,C., Valent,P. and Wieser,R. TITLE Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration JOURNAL Genes Chromosomes Cancer 47 (4), 288-298 (2008) PUBMED 18181178 REMARK GeneRIF: EVI1 and MDS1/EVI1 overexpression is associated with acute myeloid leukemia REFERENCE 6 (bases 1 to 5740) AUTHORS Aytekin,M., Vinatzer,U., Musteanu,M., Raynaud,S. and Wieser,R. TITLE Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends JOURNAL Gene 356, 160-168 (2005) PUBMED 16014322 REMARK GeneRIF: The general expression patterns of the EVI1 5'-end variants in a panel of 20 human tissues were similar, while pronounced differences were noted in response to all-trans retinoic acid. REFERENCE 7 (bases 1 to 5740) AUTHORS Mochizuki,N., Shimizu,S., Nagasawa,T., Tanaka,H., Taniwaki,M., Yokota,J. and Morishita,K. TITLE A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells JOURNAL Blood 96 (9), 3209-3214 (2000) PUBMED 11050005 REFERENCE 8 (bases 1 to 5740) AUTHORS Nucifora,G., Begy,C.R., Kobayashi,H., Roulston,D., Claxton,D., Pedersen-Bjergaard,J., Parganas,E., Ihle,J.N. and Rowley,J.D. TITLE Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations JOURNAL Proc. Natl. Acad. Sci. U.S.A. 91 (9), 4004-4008 (1994) PUBMED 8171026 REFERENCE 9 (bases 1 to 5740) AUTHORS Mitani,K., Ogawa,S., Tanaka,T., Miyoshi,H., Kurokawa,M., Mano,H., Yazaki,Y., Ohki,M. and Hirai,H. TITLE Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia JOURNAL EMBO J. 13 (3), 504-510 (1994) PUBMED 8313895 REFERENCE 10 (bases 1 to 5740) AUTHORS Morishita,K., Parganas,E., Douglass,E.C. and Ihle,J.N. TITLE Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts JOURNAL Oncogene 5 (7), 963-971 (1990) PUBMED 2115646 COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from BX640908.1, AC078985.14, BX647613.1 and AA043944.1. Summary: The protein encoded by this gene is a transcriptional regulator and oncoprotein that may be involved in hematopoiesis, apoptosis, development, and cell differentiation and proliferation. The encoded protein can interact with CTBP1, SMAD3, CREBBP, KAT2B, MAPK8, and MAPK9. This gene can undergo translocation with the AML1 gene, resulting in overexpression of this gene and the onset of leukemia. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]. Transcript Variant: This variant (6, also known as EVI1_1a) differs in the 5' UTR, lacks a portion of the 5' coding region, initiates translation at a downstream start codon, and uses an alternate in-frame splice site and lacks an alternate in-frame exon in the central coding region, compared to variant 1. The encoded isoform (e) is shorter than isoform a. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: BX640908.1, BX647613.1 [ECO:0000332] RNAseq introns :: single sample supports all introns ERS025098 [ECO:0000348] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end. PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-371 BX640908.1 1-371 372-973 AC078985.14 120459-121060 c 974-2527 BX647613.1 706-2259 2528-2628 BX640908.1 2528-2628 2629-3394 BX647613.1 2361-3126 3395-4211 BX640908.1 3395-4211 4212-5732 BX647613.1 3944-5464 5733-5740 AA043944.1 3-10 c FEATURES Location/Qualifiers source 1..5740 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="3" /map="3q26.2" gene 1..5740 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="MDS1 and EVI1 complex locus" /db_xref="GeneID:2122" /db_xref="HGNC:3498" /db_xref="MIM:165215" exon 1..1012 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" variation 973 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="a" /replace="t" /db_xref="dbSNP:1420476" misc_feature 992..994 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="upstream in-frame stop codon" exon 1013..1147 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 1148..1250 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" CDS 1202..4330 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="isoform e is encoded by transcript variant 6; MDS1 and EVI1 complex locus protein EVI1; MDS1 and EVI1 complex locus protein MDS1; oncogene EVI1; myelodysplasia syndrome-associated protein 1; zinc finger protein Evi1; AML1-EVI-1 fusion protein; ecotropic virus integration site 1 protein homolog" /codon_start=1 /product="MDS1 and EVI1 complex locus protein EVI1 isoform e" /protein_id="NP_001157472.1" /db_xref="GI:255683390" /db_xref="CCDS:CCDS54669.1" /db_xref="GeneID:2122" /db_xref="HGNC:3498" /db_xref="MIM:165215" /translation="
MKSEDYPHETMAPDIHEERQYRCEDCDQLFESKAELADHQKFPCSTPHSAFSMVEEDFQQKLESENDLQEIHTIQECKECDQVFPDLQSLEKHMLSHTEEREYKCDQCPKAFNWKSNLIRHQMSHDSGKHYECENCAKVFTDPSNLQRHIRSQHVGARAHACPECGKTFATSSGLKQHKHIHSSVKPFICEVCHKSYTQFSNLCRHKRMHADCRTQIKCKDCGQMFSTTSSLNKHRRFCEGKNHFAAGGFFGQGISLPGTPAMDKTSMVNMSHANPGLADYFGANRHPAGLTFPTAPGFSFSFPGLFPSGLYHRPPLIPASSPVKGLSSTEQTNKSQSPLMTHPQILPATQDILKALSKHPSVGDNKPVELQPERSSEERPFEKISDQSESSDLDDVSTPSGSDLETTSGSDLESDIESDKEKFKENGKMFKDKVSPLQNLASINNKKEYSNHSIFSPSLEEQTAVSGAVNDSIKAIASIAEKYFGSTGLVGLQDKKVGALPYPSMFPLPFFPAFSQSMYPFPDRDLRSLPLKMEPQSPGEVKKLQKGSSESPFDLTTKRKDEKPLTPVPSKPPVTPATSQDQPLDLSMGSRSRASGTKLTEPRKNHVFGGKKGSNVESRPASDGSLQHARPTPFFMDPIYRVEKRKLTDPLEALKEKYLRPSPGFLFHPQMSAIENMAEKLESFSALKPEASELLQSVPSMFNFRAPPNALPENLLRKGKERYTCRYCGKIFPRSANLTRHLRTHTGEQPYRCKYCDRSFSISSNLQRHVRNIHNKEKPFKCHLCDRCFGQQTNLDRHLKKHENGNMSGTATSSPHSELESTGAILDDKEDAYFTEIRNFIGNSNHGSQSPRNVEERMNGSHFKDEKALVTSQNSDLLDDEEVEDEVLLDEEDEDNDITGKTGKEPVTSNLHEGNPEDDYEETSALEMSCKTSPVRYKEEEYKSGLSALDHIRHFTDSLKMRKMEDNQYSEAELSSFSTSHVPEELKQPLHRKSKSQAYAMMLSLSDKESLHSTSHSSSNVWHSMARAAAESSAIQSISHV
" misc_feature 1202..1957 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /experiment="experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q03112.2); Region: Interaction with MAPK9, SMAD3 and probably SUV39H1" misc_feature 1466..1540 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc-finger double domain; Region: zf-H2C2_2; pfam13465" /db_xref="CDD:205643" misc_feature 1511..1576 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc finger, C2H2 type; Region: zf-C2H2; cl15478" /db_xref="CDD:210117" misc_feature 1634..1714 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc-finger double domain; Region: zf-H2C2_2; pfam13465" /db_xref="CDD:205643" misc_feature 1766..1831 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc finger, C2H2 type; Region: zf-C2H2; cl15478" /db_xref="CDD:210117" misc_feature 1853..1918 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc finger, C2H2 type; Region: zf-C2H2; cl15478" /db_xref="CDD:210117" misc_feature 2462..2503 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q03112.2); Region: Nuclear localization signal (Potential)" misc_feature 2858..2872 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q03112.2); Region: CTBP-binding motif 1 (By similarity)" misc_feature 2951..2965 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q03112.2); Region: CTBP-binding motif 2 (By similarity)" misc_feature 3170..3529 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="hypothetical protein; Region: PHA00733" /db_xref="CDD:177301" misc_feature 3374..3439 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc finger, C2H2 type; Region: zf-C2H2; cl15478" /db_xref="CDD:210117" misc_feature 3413..3487 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc-finger double domain; Region: zf-H2C2_2; pfam13465" /db_xref="CDD:205643" misc_feature 3497..3571 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /note="Zinc-finger double domain; Region: zf-H2C2_2; pfam13465" /db_xref="CDD:205643" misc_feature 3752..3754 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /experiment="experimental evidence, no additional details recorded" /note="Phosphoserine; propagated from UniProtKB/Swiss-Prot (Q03112.2); phosphorylation site" exon 1251..1467 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 1468..1615 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" variation 1521 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="a" /replace="g" /db_xref="dbSNP:34896995" STS 1564..2771 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /standard_name="Evi1" /db_xref="UniSTS:256974" STS 1564..2030 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /standard_name="Evi1" /db_xref="UniSTS:256973" exon 1616..1769 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 1770..3126 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" variation 1912 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="a" /replace="g" /db_xref="dbSNP:35594969" variation 1955 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="g" /replace="t" /db_xref="dbSNP:199968662" STS 2215..3161 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /standard_name="Evi1" /db_xref="UniSTS:506889" variation 2834 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="c" /replace="t" /db_xref="dbSNP:2276719" exon 3127..3214 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 3215..3381 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" variation 3284 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="a" /replace="c" /db_xref="dbSNP:36043407" exon 3382..3459 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 3460..3629 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" variation 3551 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="c" /replace="t" /db_xref="dbSNP:34224062" exon 3630..3774 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 3775..4011 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 4012..4195 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" exon 4196..5740 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /inference="alignment:Splign:1.39.8" STS 4214..4433 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /standard_name="SHGC-77524" /db_xref="UniSTS:47700" STS 4731..5018 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /standard_name="SGC38138" /db_xref="UniSTS:74058" variation 4918 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="c" /replace="t" /db_xref="dbSNP:1048601" variation 5532 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" /replace="g" /replace="t" /db_xref="dbSNP:1048604" polyA_signal 5712..5717 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" polyA_site 5740 /gene="MECOM" /gene_synonym="AML1-EVI-1; EVI1; MDS1; MDS1-EVI1; PRDM3" ORIGIN
cacacacacacacacacaccacacttgtgctttcaagacatcgaaacggaggctatttccctggggaaagaaatcctgcctggcgagatctccccattggttgtttacccggagaaatctacatgtttaagggggatggtgcatccataatcagtctgtccctataggacttgggtcttggcgacctttttgtgacctctcccgccagaggaggctgctgtcactttaaaaatttaaaagaggagcccgtctggcttccgatcagatcactctgggcggcgggagatagctccctttctccctcgccccgggttctttctggatggccgagcagatcctctttaaagagacagttcatgaaatagaaacccggcggctgagcttggagttgcgaaaggggacgatcccgtgagggtccaggacccgcgaaggcgctgcggaggatctgaaagggggatagagctcccctcgcctccccaggccccccaccttttcaaactctcctcctcctgcttgttttcccccattggaactgggaaggagaagtagaagttttagtgggtttcagataactttcattacacatcgggctgataagagcaagagaaagtgagaaaagagggaggtgatgtgaaccagaaggaatagctccgagctcatttaggaagggggaaaaagccaaaacacaccaaacccgggtcacccagacgaaagaagacttcatttcttgtattaaaaatacactgttggcggacaataaatccgaaacgcgtggtcctggagagcagatcctagagacggacaaagttgtcagagacccatttggaaatcgagacgcgaggcttttaaaaaattattattattatttttaaacatctctaaatgttgctcgggatcgtttgaaaggattttcgtgcaggagcgttgggggctgctgattattttattttgtttattttgattcttctgtgaatgcctattattgctgagttgaggccatagaaatctaaagatcttagacgaattttacaatgtgaagttctgcatagatgccagtcaaccagatgttggaagctggctcaagtacattagattcgctggctgttatgatcagcacaaccttgttgcatgccagataaatgatcagatattctatagagtagttgcagacattgcgccgggagaggagcttctgctgttcatgaagagcgaagactatccccatgaaactatggcgccggatatccacgaagaacggcaatatcgctgcgaagactgtgaccagctctttgaatctaaggctgaactagcagatcaccaaaagtttccatgcagtactcctcactcagcattttcaatggttgaagaggactttcagcaaaaactcgaaagcgagaatgatctccaagagatacacacgatccaggagtgtaaggaatgtgaccaagtttttcctgatttgcaaagcctggagaaacacatgctgtcacatactgaagagagggaatacaagtgtgatcagtgtcccaaggcatttaactggaagtccaatttaattcgccaccagatgtcacatgacagtggaaagcactatgaatgtgaaaactgtgccaaggttttcacggaccctagcaaccttcagcggcacattcgctctcagcatgtcggtgcccgggcccatgcatgcccggagtgtggcaaaacgtttgccacttcgtcgggcctcaaacaacacaagcacatccacagcagtgtgaagccctttatctgtgaggtctgccataaatcctatactcagttttcaaacctttgccgtcataagcgcatgcatgctgattgcagaacccaaatcaagtgcaaagactgtggacaaatgttcagcactacgtcttccttaaataaacacaggaggttttgtgagggcaagaaccattttgcggcaggtggattttttggccaaggcatttcacttcctggaaccccagctatggataaaacgtccatggttaatatgagtcatgccaacccgggccttgctgactattttggcgccaataggcatcctgctggtcttacctttccaacagctcctggattttcttttagcttccctggtctgtttccttccggcttgtaccacaggcctcctttgatacctgctagttctcctgttaaaggactatcaagtactgaacagacaaacaaaagtcaaagtcccctcatgacacatcctcagatactgccagctacacaggatattttgaaggcactatctaaacacccatctgtaggggacaataagccagtggagctccagcccgagaggtcctctgaagagaggccctttgagaaaatcagtgaccagtcagagagtagtgaccttgatgatgtcagtacaccaagtggcagtgacctggaaacaacctcgggctctgatctggaaagtgacattgaaagtgataaagagaaatttaaagaaaatggtaaaatgttcaaagacaaagtaagccctcttcagaatctggcttcaataaataataagaaagaatacagcaatcattccattttctcaccatctttagaggagcagactgcggtgtcaggagctgtgaatgattctataaaggctattgcttctattgctgaaaaatactttggttcaacaggactggtggggctgcaagacaaaaaagttggagctttaccttacccttccatgtttcccctcccattttttccagcattctctcaatcaatgtacccatttcctgatagagacttgagatcgttacctttgaaaatggaaccccaatcaccaggtgaagtaaagaaactgcagaagggcagctctgagtccccctttgatctcaccactaagcgaaaggatgagaagcccttgactccagtcccctccaagcctccagtgacacctgccacaagccaagaccagcccctggatctaagtatgggcagtaggagtagagccagtgggacaaagctgactgagcctcgaaaaaaccacgtgtttgggggaaaaaaaggaagcaacgtcgaatcaagacctgcttcagatggttccttgcagcatgcaagacccactcctttctttatggaccctatttacagagtagagaaaagaaaactaactgacccacttgaagctttaaaagagaaatacttgaggccttctccaggattcttgtttcacccacaaatgtcagctattgaaaacatggcagaaaagctagagagcttcagtgccctgaaacctgaggccagtgagctcttacagtcagtgccctctatgttcaacttcagggcgcctcccaatgccctgccagagaaccttctgcggaagggaaaggagcgctatacctgcagatactgtggcaagatttttccaaggtctgcaaacctaacacggcacttgagaacccacacaggagagcagccttacagatgcaaatactgtgacagatcatttagcatatcttctaacttgcaaaggcatgttcgcaacatccacaataaagagaagccatttaagtgtcacttatgtgataggtgttttggtcaacaaaccaatttagacagacacctaaagaaacatgagaatgggaacatgtccggtacagcaacatcgtcgcctcattctgaactggaaagtacaggtgcgattctggatgacaaagaagatgcttacttcacagaaattcgaaatttcattgggaacagcaaccatggcagccaatctcccaggaatgtggaggagagaatgaatggcagtcattttaaagatgaaaaggctttggtgaccagtcaaaattcagacttgctggatgatgaagaagttgaagatgaggtgttgttagatgaggaggatgaagacaatgatattactggaaaaacaggaaaggaaccagtgacaagtaatttacatgaaggaaaccctgaggatgactatgaagaaaccagtgccctggagatgagttgcaagacatccccagtgaggtataaagaggaagaatataaaagtggactttctgctctagatcatataaggcacttcacagatagcctcaaaatgaggaaaatggaagataatcaatattctgaagctgagctgtcttcttttagtacttcccatgtgccagaggaacttaagcagccgttacacagaaagtccaaatcgcaggcatatgctatgatgctgtcactgtctgacaaggagtccctccattctacatcccacagttcttccaacgtgtggcacagtatggccagggctgcggcggaatccagtgctatccagtccataagccacgtatgacgttatcaaggttgaccagagtgggaccaagtccaacagtagcatggctctttcatataggactatttacaagactgctgagcagaatgccttataaacctgcagggtcactcatctaaagtctagtgaccttaaactgaatgatttaaaaaagaaaagaaagaaaaaagaaactatttattctcgatattttgttttgcacagcaaaggcagctgctgacttctggaagatcaatcaatgcgacttaaagtgattcagtgaaaacaaaaaacttggtgggctgaaggcatcttccagtttaccccaccttagggtatgggtgggtgagaagggcagttgagatggcagcattgatatgaatgaacactccatagaaactgaattctcttttgtacaagatcacctgacatgattgggaacagttgcttttaattacagatttaatttttttcttcgttaaagttttatgtaatttaaccctttgaagacagaagtagttggatgaaatgcacagtcaattattatagaaactgataacagggagtacttgttcccccttttgccttcttaagtacattgtttaaaactagggaaaaagggtatgtgtatattgtaaactatggatgttaacactcaaagaggttaagtcagtgaagtaacctattcatcaccagtaccgctgtaccactaataaattgtttgccaaatccttgtaataacatcttaattttagacaatcatgtcactgtttttaatgtttatttttttgtgtgtgttgcgtgtatcatgtatttatttgttggcaaactattgtttgttgattaaaatagcactgttccagtcagccactactttatgacgtctgaggcacacccctttccgaatttcaaggaccaaggtgacccgacctgtgtatgagagtgccaaatggtgtttggcttttcttaacattcctttttgtttgtttgttttgttttccttcttaatgaactaaatacgaatagatgcaacttagtttttgtaatactgaaatcgattcaattgtataaacgattataatttctttcatggaagcatgattcttctgattaaaaactgtactccatattttatgctggttgtctgcaagcttgtgcgatgttatgttcatgttaatcctatttgtaaaatgaagtgttcccaaccttatgttaaaagagagaagtaaataacagactgtattcagttattttgccctttattgaggaaccagatttgttttctttttgtttgtaatctcattttgaaataatcagcaagttgaggtactttcttcaaatgctttgtacaatataaactgttatgcctttcagtgcattactatgggaggagcaactaaaaaataaagacttacaaaaaggagtattttt
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:2122 -> Molecular function: GO:0003677 [DNA binding] evidence: ISS GeneID:2122 -> Molecular function: GO:0003700 [sequence-specific DNA binding transcription factor activity] evidence: IDA GeneID:2122 -> Molecular function: GO:0003700 [sequence-specific DNA binding transcription factor activity] evidence: TAS GeneID:2122 -> Molecular function: GO:0005515 [protein binding] evidence: IPI GeneID:2122 -> Molecular function: GO:0042803 [protein homodimerization activity] evidence: IDA GeneID:2122 -> Molecular function: GO:0046872 [metal ion binding] evidence: IEA GeneID:2122 -> Biological process: GO:0001701 [in utero embryonic development] evidence: IEA GeneID:2122 -> Biological process: GO:0001780 [neutrophil homeostasis] evidence: IEA GeneID:2122 -> Biological process: GO:0006351 [transcription, DNA-dependent] evidence: IEA GeneID:2122 -> Biological process: GO:0006355 [regulation of transcription, DNA-dependent] evidence: TAS GeneID:2122 -> Biological process: GO:0006915 [apoptotic process] evidence: IEA GeneID:2122 -> Biological process: GO:0006954 [inflammatory response] evidence: IEA GeneID:2122 -> Biological process: GO:0009605 [response to external stimulus] evidence: IEA GeneID:2122 -> Biological process: GO:0009617 [response to bacterium] evidence: IEA GeneID:2122 -> Biological process: GO:0009791 [post-embryonic development] evidence: IEA GeneID:2122 -> Biological process: GO:0030154 [cell differentiation] evidence: IEA GeneID:2122 -> Biological process: GO:0030512 [negative regulation of transforming growth factor beta receptor signaling pathway] evidence: IDA GeneID:2122 -> Biological process: GO:0030900 [forebrain development] evidence: IEA GeneID:2122 -> Biological process: GO:0035115 [embryonic forelimb morphogenesis] evidence: IEA GeneID:2122 -> Biological process: GO:0035116 [embryonic hindlimb morphogenesis] evidence: IEA GeneID:2122 -> Biological process: GO:0042127 [regulation of cell proliferation] evidence: IEA GeneID:2122 -> Biological process: GO:0043069 [negative regulation of programmed cell death] evidence: IMP GeneID:2122 -> Biological process: GO:0045892 [negative regulation of transcription, DNA-dependent] evidence: IDA GeneID:2122 -> Biological process: GO:0045893 [positive regulation of transcription, DNA-dependent] evidence: IDA GeneID:2122 -> Biological process: GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] evidence: IEA GeneID:2122 -> Biological process: GO:0046329 [negative regulation of JNK cascade] evidence: IMP GeneID:2122 -> Biological process: GO:0051726 [regulation of cell cycle] evidence: IDA GeneID:2122 -> Biological process: GO:0060039 [pericardium development] evidence: IEA GeneID:2122 -> Biological process: GO:0071425 [hematopoietic stem cell proliferation] evidence: ISS GeneID:2122 -> Biological process: GO:0072001 [renal system development] evidence: IEA GeneID:2122 -> Cellular component: GO:0000118 [histone deacetylase complex] evidence: IDA GeneID:2122 -> Cellular component: GO:0005634 [nucleus] evidence: IDA GeneID:2122 -> Cellular component: GO:0016607 [nuclear speck] evidence: IDA
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.